Australian tennis coach and former professional player Marinko Matosevic has been suspended for four years under the Tennis Anti-Doping Programme, ending his coaching career and eliminating his involvement with rising Australian players he had mentored.
On 16 March 2026, the independent tribunal chaired by Michael Heron KC upheld the charges, finalising a disciplinary process that began quietly in 2024. An independent tribunal determined that Matosevic committed five anti-doping rule violations between 2018 and 2020, including use of a prohibited method through blood doping while an active player and facilitating another player to blood dope, providing advice to other players on how to avoid positive tests, and use and possession of the prohibited substance clenbuterol.
Matosevic, 40, reached a career-high singles ranking of 39 in 2013, retired from the sport in 2018 and has since become a coach, working with Australian players Chris O'Connell and Jordan Thompson. The ban means he cannot coach, compete, or attend sanctioned tennis events for four years, severing his connection to professional tennis entirely.
The path to this outcome reveals a procedural question that has become contentious within the sport: how seriously should questions about investigative fairness be treated when they come from someone admitting wrongdoing? Matosevic denied all charges throughout the process until admitting to blood doping in media comments shortly before the hearing was scheduled to take place. In the weeks preceding the hearing, Matosevic ceased to engage with the arbitration process, before issuing a statement via media, making an admission to one blood doping charge.
Matosevic's motivation for the blood transfusion stemmed from health difficulties he faced at the time. In his February statement, he explained that health issues in 2017 led him to undergo the procedure in Morelos, Mexico, in February 2018. "I was so disgusted with myself, I retired the following week at the age of 32 and a half", he said, noting that he spent nearly two years away from tennis before returning to coaching.
Yet alongside his admission came a broader critique of the International Tennis Integrity Agency's investigation methods. "They take your phone under threatening circumstances and build legal cases from photos and assumptions drawn from text messages that literally date back more than five years", Matosevic said. He concluded that "the current systems in tennis should be dismantled".
The tribunal dismissed Matosevic's public allegations relating to the integrity of the ITIA's investigation process as without merit, and found that the ITIA "acted within the authority conferred by the TADP". The independent panel ruling suggests that even if investigative methods are imperfect, they do not invalidate evidence obtained or findings of fact.
There is tension here worth acknowledging. Questions about procedural fairness in anti-doping cases have surfaced in other high-profile cases in tennis. Some tennis players, notably 24-time major champion Novak Djokovic, have been critical of the way cases were handled, saying there was a sense of favouritism toward the sport's biggest stars. In response, ITIA CEO Karen Moorhouse acknowledged that "the process can come at both a financial and emotional cost". Yet those concerns about process fairness are not equivalent to evidence that Matosevic's specific violations did not occur.
Matosevic's results and prize money from the Morelos and Indian Wells ATP Challenger events in February 2018, around the time of the blood doping violation, have been disqualified. His suspension will end on 15 March 2030, subject to repayment of outstanding prize money.
For Australian tennis, the timing creates a loss. Matosevic had been coaching O'Connell and Thompson as they developed their careers, and his absence removes an experienced mentor from the domestic coaching ecosystem. The broader lesson, however, remains less about Matosevic's case specifically and more about the consequences of doping in any context: admission, remorse, and understanding of harm do not reverse the regulatory machinery once it begins.